Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Boom

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Infection and Immunity|October 18, 2000
Latency-associated peptide of transforming growth factor beta enhances mycobacteriocidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 miceK A Wilkinson, T D Martin, S M Reba, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 2007
Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and preventionP Srikantiah, R Lin, M Walusimbi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosisE H Noss, R K Pai, T J Sellati, et al.
Research in Microbiology|June 1, 1993
Screening of a cosmid library of Mycobacterium bovis BCG in Mycobacterium smegmatis for novel T-cell stimulatory antigensL E Averill, U Cavallo, R S Wallis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 16, 2013
Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatmentC M Bark, P Gitta, S Ogwang, et al.
Tuberculosis (Edinburgh, Scotland)|March 1, 2011
Time to detection of Mycobacterium tuberculosis as an alternative to quantitative culturesC M Bark, A Okwera, M L Joloba, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 30, 2026
Incidence of <i>Mycobacterium tuberculosis</i> infection in an African city with endemic TBN Kiwanuka, H T Quach, R Kakaire, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 15, 2013
Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban UgandaH Luzze, D F Johnson, K Dickman, et al.
The Journal of Infectious Diseases|August 19, 2011
A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μLM W Nanteza, H Mayanja-Kizza, E Charlebois, et al.
Journal of Clinical Microbiology|November 20, 2009
Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapyL Li, C S Mahan, M Palaci, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Infection and Immunity|October 18, 2000
Latency-associated peptide of transforming growth factor beta enhances mycobacteriocidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 miceK A Wilkinson, T D Martin, S M Reba, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 2007
Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and preventionP Srikantiah, R Lin, M Walusimbi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosisE H Noss, R K Pai, T J Sellati, et al.
Research in Microbiology|June 1, 1993
Screening of a cosmid library of Mycobacterium bovis BCG in Mycobacterium smegmatis for novel T-cell stimulatory antigensL E Averill, U Cavallo, R S Wallis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 16, 2013
Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatmentC M Bark, P Gitta, S Ogwang, et al.
Tuberculosis (Edinburgh, Scotland)|March 1, 2011
Time to detection of Mycobacterium tuberculosis as an alternative to quantitative culturesC M Bark, A Okwera, M L Joloba, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 30, 2026
Incidence of <i>Mycobacterium tuberculosis</i> infection in an African city with endemic TBN Kiwanuka, H T Quach, R Kakaire, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 15, 2013
Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban UgandaH Luzze, D F Johnson, K Dickman, et al.
The Journal of Infectious Diseases|August 19, 2011
A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μLM W Nanteza, H Mayanja-Kizza, E Charlebois, et al.
Journal of Clinical Microbiology|November 20, 2009
Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapyL Li, C S Mahan, M Palaci, et al.
Pageof 7